Real-world evidence for neovascular age-related macular degeneration: a practical approach.
作者信息
Teo Kelvin Yi Chong
机构信息
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
Duke-NUS Medical School, National University of Singapore, Singapore, Singapore.
出版信息
Eye (Lond). 2023 Jan;37(1):1-3. doi: 10.1038/s41433-022-02151-x. Epub 2022 Jul 8.
Abstract
摘要
相似文献
1
Real-world evidence for neovascular age-related macular degeneration: a practical approach.新生血管性年龄相关性黄斑变性的真实世界证据：一种实用方法。
Eye (Lond). 2023 Jan;37(1):1-3. doi: 10.1038/s41433-022-02151-x. Epub 2022 Jul 8.
2
Macular atrophy development in neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性中的黄斑萎缩发展
Eur J Ophthalmol. 2022 Jan;32(1):NP307-NP308. doi: 10.1177/1120672120948730. Epub 2020 Aug 5.
3
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration in 2022: Same, same but different.2022年抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性：相同又不同。
Clin Exp Ophthalmol. 2022 Apr;50(3):270-273. doi: 10.1111/ceo.14057. Epub 2022 Feb 16.
4
Achieving balance in the treatment and monitoring of neovascular age-related macular degeneration in the real world: lessons from the Netherlands cohort of the AURA study.在现实世界中实现新生血管性年龄相关性黄斑变性治疗与监测的平衡：来自AURA研究荷兰队列的经验教训
Acta Ophthalmol. 2019 Mar;97(2):e323-e324. doi: 10.1111/aos.13946. Epub 2018 Oct 14.
5
Ranibizumab Injection (Susvimo) Implant Septum Dislodgement in a Patient With Neovascular Age-Related Macular Degeneration.雷珠单抗注射液（Susvimo）植入物隔膜移位在一名新生血管性年龄相关性黄斑变性患者中的病例报告
JAMA Ophthalmol. 2022 Aug 1;140(8):832. doi: 10.1001/jamaophthalmol.2022.2495.
6
Radiotherapy for anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration.抗血管内皮生长因子注射治疗新生血管性年龄相关性黄斑变性的放射治疗
Lancet. 2024 Jul 6;404(10447):4-5. doi: 10.1016/S0140-6736(24)00915-2. Epub 2024 Jun 11.
7
Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry.新生血管性年龄相关性黄斑变性：真实世界 Fight Retinal Blindness！注册研究结果的综述。
Clin Exp Ophthalmol. 2021 Sep;49(7):652-663. doi: 10.1111/ceo.13949. Epub 2021 Jun 21.
8
Baseline characteristics and progression of neovascular age-related macular degeneration in patients receiving over 60 intravitreal injections of anti-vascular endothelial growth factor.接受超过 60 次抗血管内皮生长因子玻璃体腔内注射治疗的新生血管性年龄相关性黄斑变性患者的基线特征和进展。
Rom J Ophthalmol. 2023 Jul-Sep;67(3):260-266. doi: 10.22336/rjo.2023.43.
9
Steroid/AntiVascular Endothelial Growth Factor Combination Therapy for Neovascular Age-Related Macular Degeneration.类固醇/抗血管内皮生长因子联合疗法治疗新生血管性年龄相关性黄斑变性
J Ocul Pharmacol Ther. 2024 Apr;40(3):197-198. doi: 10.1089/jop.2024.0013. Epub 2024 Mar 6.
10
Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration.抗 VEGF 药物治疗新生血管性年龄相关性黄斑变性的 10 年真实世界临床经验。
Acta Ophthalmol. 2020 Mar;98(2):132-138. doi: 10.1111/aos.14183. Epub 2019 Jul 8.
引用本文的文献
1
Cost Drivers of Pars Plana Vitrectomy for Retinal Detachment: Time-Driven Activity-Based Costing Analysis.视网膜脱离玻璃体切除术的成本驱动因素：基于时间驱动作业成本法的分析
J Vitreoretin Dis. 2024 Oct 10:24741264241279624. doi: 10.1177/24741264241279624.
Zotero 插件